Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants
Clinical trial NCT06737042 · COMPLETED
Trial details
- NCT number
- NCT06737042
- Sponsor
- Gan and Lee Pharmaceuticals, USA
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-24
- Primary completion
- 2026-02-27
- Enrollment
- 326
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.